SEATTLE, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SEATTLE SCIENCE FOUNDATION, founded in 2006, is a community nonprofit in the Medical Research sector that reported $2.5M in total revenue in fiscal year 2023. Revenue decreased 6% compared to the prior year. Expenses of $3.0M exceeded revenue, resulting in a 21% operating deficit.
DEDICATED TO ADVANCING THE QUALITY OF PATIENT CARE THROUGH EDUCATION, RESEARCH, INNOVATION AND TECHNOLOGY.
4. PLUEMER J, FREYVERT Y, PRATT N, ROBINSON JE, COOKE JA, TATARYN ZL, PIERRE CA, GODOLIAS P, FRIELER S, VON GLINSKI A, YILMAZ E, DAHER ZA, AL-AWADI HA, YOUNG MH, OSKOUIAN RJ, CHAPMAN JR. A NOVEL...
4. PLUEMER J, FREYVERT Y, PRATT N, ROBINSON JE, COOKE JA, TATARYN ZL, PIERRE CA, GODOLIAS P, FRIELER S, VON GLINSKI A, YILMAZ E, DAHER ZA, AL-AWADI HA, YOUNG MH, OSKOUIAN RJ, CHAPMAN JR. A NOVEL SCORING SYSTEM CONCEPT FOR DE NOVO SPINAL INFECTION TREATMENT, THE SPINAL INFECTION TREATMENT EVALUATION SCORE (SITE SCORE): A PROOF-OF-CONCEPT STUDY. J NEUROSURG SPINE. 2022 DEC 9;3 (3):396-404. DOI: 10.3171/2022.11.SPINE22719. PMID: 36681973. HTTPS://PUBMED.NCBI.NLM.NIH.GOV/36681973/ 5. PLUEMER J, FREYVERT Y, PRATT N, ROBINSON JE, COOKE JA, TATARYN ZL, GODOLIAS P, DAHERZA, OSKOUIAN RJ, CHAPMAN JR. AN ASSESSMENT OF THE SAFETY OF SURGERY AND HARDWARE PLACEMENT IN DE-NOVO SPINAL INFECTIONS. A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE LITERATURE. GLOBAL SPINE J. 2023 JUN;13(5):1418-1428. DOI:10.1177/21925682221145603. EPUB 2022 DEC 12. PMID: 36510352; PMCID: PMC10416600. HTTPS://PUBMED.NCBI.NLM.NIH.GOV/36510352/
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,451,068 | $2,616,778 | -0.1% |
| Expenses | $2,977,740 | $2,822,555 | +0.1% |
| Net Income | $-526,672 | $-205,777 | +1.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| GUY HUDSON MD | DIRECTOR | 0.50 |
Director
|
$0 | $39,652 | $6,195,258 |
| GREG HOFFMAN | PRESIDENT | 0.50 |
Officer
|
$0 | $334,955 | $3,539,549 |
| JO ANN ESCASA-HAIGH | EVP/ASSISTANT TREASURER | 0.50 |
Officer
|
$0 | $10,754 | $3,302,551 |
| ANNA NEWSOM | SECRETARY | 1.00 |
Officer
|
$0 | $412,545 | $2,329,749 |
| ROD OSKOUIAN MD | BOARD PRESIDENT AND CEO | 1.00 |
Officer
Director
|
$0 | $116,104 | $1,690,948 |
| BETSY VO | ASSISTANT SECRETARY | 1.00 |
Officer
|
$0 | $92,726 | $666,172 |
| JOHN WHIPPLE | FRMR SECRETARY | 0.00 |
|
$0 | $0 | $541,701 |
| ALEXIS TAKASUMI-WEST | CHIEF OPERATING OFFICER | 55.00 |
Key Emp
|
$275,000 | $16,353 | $291,353 |
| LINDA SAHLIN | DIRECTOR - EDUCATION | 50.00 |
Highest
|
$143,004 | $12,376 | $155,380 |
| GARY HOLLEY | LAB MANAGER | 50.00 |
Highest
|
$113,581 | $11,494 | $125,075 |
| DAVID SABEY | BOARD CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOE SABEY | DIRECTOR | 0.50 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $2,451,068 | $2,977,740 | $3,099,199 | $-526,672 |
| 2022 | $2,616,778 | $2,822,555 | $3,643,216 | $-205,777 |
| 2021 | $2,724,723 | $2,900,968 | $3,795,510 | $-176,245 |
| 2020 | $2,143,774 | $2,573,121 | $3,967,786 | $-429,347 |
| 2019 | $3,751,024 | $3,591,646 | $4,510,770 | $159,378 |
| 2018 | $4,757,409 | $3,812,674 | $4,339,030 | $944,735 |
Compare SEATTLE SCIENCE FOUNDATION with other nonprofits in Washington and across the country.